Adicet Bio
ACET
32 hedge funds and large institutions have $108M invested in Adicet Bio in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 25 closing their positions.
197% more capital invested
Capital invested by funds: $36.2M → $108M (+$71.4M)
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
2.52% more ownership
Funds ownership: 0.41% → 2.93% (+2.5%)
40% less funds holding
Funds holding: 53 → 32 (-21)
84% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$95.1M |
| 2 |
JJIJ
Johnson & Johnson Innovation - JJDC
New Brunswick,
New Jersey
|
+$10.5M |
| 3 |
AC
AWH Capital
Dallas,
Texas
|
+$2.45M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.07M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$834K |
| 2 |
Two Sigma Investments
New York
|
-$515K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$326K |
| 4 |
EGM
Engineers Gate Manager
New York
|
-$265K |
| 5 |
D.E. Shaw & Co
New York
|
-$212K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$3K | -12 | Closed |
|
52
Group One Trading
Chicago,
Illinois
| – | -$1K | -3 | Closed |
|
53
Osaic Holdings
Scottsdale,
Arizona
| – | -$253 | -1 | -50% |
|
|
PCM
54
Penserra Capital Management
Orinda,
California
| – | +$759 | +3 | New |
|
ACET Hedge Fund Activity: Q3 2020 in Review
32 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q3 2020, worth a combined $108M — up 197% from $36.2M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of ACET and 4 opened new positions — a net loss of 21 holders — while 10 trimmed existing stakes and 12 added.
The largest buyer was OrbiMed, adding an estimated $95.1M. The largest seller was Anson Funds Management, exiting entirely with an estimated $834K sold.
- 32 institutional investors held Adicet Bio (ACET) as of Q3 2020, down from 53 in Q2 2020.
- Funds reported $108M of Adicet Bio stock for Q3 2020, up 197% quarter-over-quarter.
- 4 funds opened new Adicet Bio positions in Q3 2020 and 25 closed out, a net change of -21 holders.
- The largest Adicet Bio buyer in Q3 2020 was OrbiMed, an estimated $95.1M added.
- The largest Adicet Bio seller in Q3 2020 was Anson Funds Management, an estimated $834K sold.
Based on aggregated 13F filings for Q3 2020.